1-Propyl-5-MeO-AMT

Pharmaceutical compound From Wikipedia, the free encyclopedia

1-Propyl-5-MeO-AMT, also known as 1-propyl-5-methoxy-α-methyltryptamine, is a serotonin receptor modulator of the tryptamine, α-alkyltryptamine, and 5-methoxytryptamine families.[1][2][3] It is the 1-propyl derivative of 5-methoxy-α-methyltryptamine (5-MeO-AMT).[3]

Other names1-Propyl-5-MeO-DMT; 1-Pr-5-MeO-DMT; 1-Propyl-5-methoxy-α-methyltryptamine; N1-n-Propyl-5-methoxy-α-methyltryptamine
PubChem CID
Quick facts Clinical data, Other names ...
1-Propyl-5-MeO-AMT
Clinical data
Other names1-Propyl-5-MeO-DMT; 1-Pr-5-MeO-DMT; 1-Propyl-5-methoxy-α-methyltryptamine; N1-n-Propyl-5-methoxy-α-methyltryptamine
Drug classSerotonin receptor modulator; Serotonin 5-HT2A receptor modulator
Identifiers
  • 1-(5-methoxy-1-propylindol-3-yl)propan-2-amine
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC15H22N2O
Molar mass246.354 g·mol−1
3D model (JSmol)
  • CCCN1C=C(C2=C1C=CC(=C2)OC)CC(C)N
  • InChI=1S/C15H22N2O/c1-4-7-17-10-12(8-11(2)16)14-9-13(18-3)5-6-15(14)17/h5-6,9-11H,4,7-8,16H2,1-3H3
  • Key:DAGLCFOMYRIMJJ-UHFFFAOYSA-N
Close

Whereas most tryptamines are highly non-selective in terms of binding to serotonin receptors, 1-propyl-5-MeO-AMT shows selectivity for the serotonin 5-HT2A receptor.[1][2][3] Its affinities (Ki) for serotonin receptors were 12 nM for the serotonin 5-HT2A receptor, 120 nM for the serotonin 5-HT2C receptor, 5,000 nM for the serotonin 5-HT1B receptor, 7,100 nM for the serotonin 5-HT1A receptor, and >10,000 nM for the serotonin 5-HT1D receptor, whereas other serotonin receptors were not reported.[3] Its capacity and potency in activating the serotonin receptors was also not reported.[3]

The drug was developed by Richard Glennon and colleagues and was first described in 1990.[3] At the time, it was described as the most 5-HT2A receptor-selective tryptamine known to date.[3]

See also

References

Related Articles

Wikiwand AI